A phase II study of tinostamustine in patients (pts) with advanced solid tumours

被引：0
|
作者：
Tinker, Anna
Strauss, James Fredric
Schneider, Reva
Chugh, Rashmi
Curigliano, Giuseppe
Di Nicola, Massimo A.
Oaknin, Ana
Janik, Tomas
Hilgier, Kasia
Manamley, Nick
Kummar, Shivaani
机构：
[1] BC Canc Vancouver, Vancouver, BC, Canada
[2] Mary Crowley Canc Res, Dallas, TX USA
[3] Univ Michigan, Ann Arbor, MI USA
[4] Univ Milan, European Inst Oncol, IRCCS, Milan, Italy
[5] Fdn IRCCS Ist Nazl, Milan, Italy
[6] Hosp Univ Vall dHebron, Gynaecol Canc Programme, Vall dHebron Inst Oncol VHIO, Vall dHebron Barcelona Hosp Campus, Barcelona, Spain
[7] Mundipharma Res Ltd, Cambridge, England
[8] Oregon Hlth & Sci Univ, Div Hematol & Med Oncol, Portland, OR USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3021
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A phase I study of tinostamustine in patients (pts) with advanced solid tumours
    Mita, A.
    Loeffler, M.
    Bui, N.
    Remmy, D.
    Mehrling, T.
    Mita, M.
    Rimel, B. J.
    Natale, R. B.
    Kummar, S.
    ANNALS OF ONCOLOGY, 2019, 30 : 177 - +
  • [2] Results from a phase I/II trial of tinostamustine monotherapy in advanced solid tumours (NCT03345485): Safety and efficacy in a subset of patients (pts) with soft tissue sarcoma (STS)
    Chugh, R.
    Kummar, S.
    Schneider, R. E.
    Janik, T.
    Manamley, N.
    Hilgier, K.
    Strauss, J.
    ANNALS OF ONCOLOGY, 2023, 34 : S1048 - S1048
  • [3] Phase I study of ATN-224 in patients (pts) with advanced solid tumours.
    Lowndes, S. A.
    Adams, A.
    Timms, A.
    Middleton, M.
    Hayward, C.
    Reich, S. D.
    Mazar, A. P.
    Harris, A. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 95S - 95S
  • [4] Phase Ib study of ribociclib (R) plus trametinib (T) in patients (pts) with metastatic/advanced solid tumours
    LoRusso, P.
    Fakih, M.
    De Vos, F. Y. F. L.
    Beck, J. T.
    Merchan, J.
    Shapiro, G.
    Lin, C-C.
    Desai, J.
    Spratlin, J.
    Cascella, T.
    Sandalic, L.
    Abdelhady, A. M.
    Boran, A.
    Gasal, E.
    Janku, F.
    Van Cutsem, E.
    ANNALS OF ONCOLOGY, 2020, 31 : S484 - S484
  • [5] PHASE I STUDY OF AXITINIB (AG-013736) IN COMBINATION WITH CHEMOTHERAPY IN PATIENTS (PTS) WITH ADVANCED SOLID TUMOURS
    Martin, L. P.
    Kozloff, M.
    Herbst, R. S.
    Samuel, T. A.
    Kim, S.
    Rosbrook, B.
    Tortorici, M.
    Tarazi, J.
    Olszanski, A. J.
    Cohen, R. B.
    ANNALS OF ONCOLOGY, 2008, 19 : 157 - 157
  • [6] LEAP-005: Phase II study of lenvatinib (len) plus pembrolizumab (pembro) in patients (pts) with previously treated advanced solid tumours
    Lwin, Z.
    Gomez-Roca, C.
    Saada-Bouzid, E.
    Yanez, E.
    Longo Munoz, F.
    Im, S-A.
    Castanon, E.
    Senellart, H.
    Graham, D.
    Voss, M.
    Doherty, M.
    Lopez, J.
    Ghori, R.
    Kubiak, P.
    Jin, F.
    Norwood, K.
    Chung, H. C.
    ANNALS OF ONCOLOGY, 2020, 31 : S1170 - S1170
  • [7] RESULTS FROM A PHASE I/II TRIAL OF TINOSTAMUSTINE MONOTHERAPY IN ADVANCED SOLID TUMOURS (NCT03345485): SAFETY AND EFFICACY IN A SUBSET OF PATIENTS WITH ADVANCED OVARIAN CANCER (OVCA)
    Tinker, Anna V.
    Chugh, Rashmi
    Curigliano, Giuseppe
    Kummar, Shivaani
    Schneider, Reva
    Strauss, James
    Janik, Tomas
    Manamley, Nick
    Hilgier, Kasia
    Oaknin, Ana
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 : A252 - A252
  • [8] A phase study of OGT 719 in patients with advanced solid tumours
    Cassidy, J
    Carmichael, J
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S287 - S288
  • [9] Dose escalation of tinostamustine in patients with advanced solid tumors
    Mita, Alain
    Loeffler, Markus
    Bui, Nam
    Mehrling, Thomas
    Rimmel, Bobbie J.
    Natale, Ronald B.
    Kummar, Shivaani
    CANCER RESEARCH, 2019, 79 (13)
  • [10] Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours
    Jones, Robin L.
    Ratain, Mark J.
    O'Dwyer, Peter J.
    Siu, Lillian L.
    Jassem, Jacek
    Medioni, Jacques
    DeJonge, Maja
    Rudin, Charles
    Sawyer, Michael
    Khayat, David
    Awada, Ahmad
    de Vos-Geelen, Judith M. P. G. M.
    Evans, T. R. Jeffry
    Obel, Jennifer
    Brockstein, Bruce
    DeGreve, Jacques
    Baurain, Jean-Francois
    Maki, Robert
    D'Adamo, David
    Dickson, Mark
    Undevia, Samir
    Geary, David
    Janisch, Linda
    Bedard, Philippe L.
    Razak, Albiruni R. Abdul
    Kristeleit, Rebecca
    Vitfell-Rasmussen, Joanna
    Walters, Ian
    Kaye, Stan B.
    Schwartz, Gary
    EUROPEAN JOURNAL OF CANCER, 2019, 120 : 132 - 139
12345